Kalaris Therapeutics

KLRS

Capitalización de mercado USD 47.6 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Samsara BioCapital Palo Alto, California	USD 52.4 M	-USD 348 k	-66,906	-0.5%
2	2 RTW Investments New York	USD 5.29 M	–	–	–
3	3 Alyeska Investment Group Chicago, Illinois	USD 2.33 M	–	–	–
4	SL 4 Siren LLC Greenwich, Connecticut	USD 1.77 M	–	–	–
5	5 Vanguard Capital Management Malvern, Pennsylvania	USD 1.62 M	+USD 745 k	+143,364	+56%
6	6 Ikarian Capital Dallas, Texas	USD 1.47 M	–	–	–
7	7 UBS Group Zurich, Switzerland	USD 1.07 M	+USD 1.33 M	+255,947	+4,139%
8	8 Renaissance Technologies New York	USD 608 k	+USD 432 k	+83,200	+126%
9	9 Marshall Wace London, United Kingdom	USD 567 k	+USD 370 k	+71,322	+105%
10	10 Geode Capital Management Boston, Massachusetts	USD 464 k	+USD 138 k	+26,492	+30%
11	11 ADAR1 Capital Management Austin, Texas	USD 407 k	–	–	–
12	12 Woodline Partners San Francisco, California	USD 407 k	–	–	–
13	WT 13 WHI Trust Chicago, Illinois	USD 397 k	–	–	–
14	14 Raymond James Financial St Petersburg, Florida	USD 395 k	-USD 113 k	-21,723	-18%
15	15 Citadel Advisors Miami, Florida	USD 390 k	+USD 497 k	+95,772	Nuevas
16	16 Boothbay Fund Management New York	USD 376 k	–	–	–
17	VA 17 Verdad Advisers Boston, Massachusetts	USD 327 k	+USD 417 k	+80,297	Nuevas
18	18 Morgan Stanley New York	USD 294 k	+USD 176 k	+33,982	+89%
19	19 Vanguard Fiduciary Trust Malvern, Pennsylvania	USD 269 k	+USD 153 k	+29,462	+80%
20	20 BlackRock New York	USD 222 k	+USD 95.6 k	+18,399	+51%
21	21 Belpointe Asset Management Reno, Nevada	USD 163 k	–	–	–
22	22 Fortis Capital Advisors Prairie Village, Kansas	USD 163 k	–	–	–
23	23 Pale Fire Capital SE Prague, Czech Republic	USD 161 k	+USD 206 k	+39,626	Nuevas
24	24 Squarepoint New York	USD 158 k	-USD 5.18 k	-998	-3%
25	25 Bridgeway Capital Management Houston, Texas	USD 132 k	+USD 51.9 k	+10,000	+44%

Kalaris Therapeutics KLRS Capitalización de mercado USD 47.6 M

Kalaris Therapeutics

KLRS

Capitalización de mercado USD 47.6 M